Cite

HARVARD Citation

    Fiore, V. et al. (2021). Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case‐control study. Liver international. pp. 271-275. [Online]. 
  
Back to record